Do You Have a Diabetes Drug Lawsuit in Arkansas?
Diabetes patients in Arkansas should be aware that some of the popular diabetes drugs available today have been reported to cause cancer, problems in the pancreas, and thyroid issues. This includes some of the most popular drugs on the market, including Byetta, Bydureon, Victoza, Januvia, and Janumet. Throughout the state of Arkansas, patients have taken this drug and could be at risk of developing a serious medical condition as a result. While these drugs are still available on the market, they are currently facing thousands of lawsuits. Arkansas residents should be aware of the possible connection between these drugs and serious medical conditions.
This drug was approved by the FDA in 2005 to treat type II diabetes by using as active ingredient called exantide. Amylin Pharmaceuticals grossed more than $700 million in sales from this product with more than 7 million prescriptions written. However, it has been claimed that this drug can actually cause problems like pancreatic cancer. Other patients have reported problems like vomiting, hypertension, chest pain, and elevated heart rate. As a result, the FDA issued an alert in 2007 and the manufacturer has been ordered to conduct studies into the safety of the drug.
Launched in 2012, this drug received approval to be injected into the thigh or upper arm for patients suffering from type II diabetes. Although it has only been on the market for two years, industry professionals have noted problems with Bydureon. While it is able to properly adjust sugar levels, it can allegedly cause pancreatic cancer. In addition to this, the drug has been alleged to cause a wide range of other medical problems. As a result of this, Bydureon has been the subject of diabetes drug lawsuits over the past couple of years.
This drug was marketed by Novo Nordisk after receiving approval from the FDA in January 2012 to treat type II diabetes. The drug is taken once a day and is easily injected by patients for convenience. Unfortunately, this convenience could come at a price because it has been reported to cause organ failure and personal disabilities. The drug is still on the market, but the FDA asked the company to conduct a five-year study to determine its negative effects.
Originally launched in 2006 by Merck, Januvia received approval from the FDA to treat type II diabetes. The drug functions by assisting the body in creating insulin to compensate for the difficulties of diabetes. However, the drug has been found to potentially cause pancreatitis, thyroid cancer, and other issues. Janumet is another diabetes drug that is similar to Januvia, and is also facing lawsuits.
Injured After Using a Diabetes Drug?
Were you diagnosed with a serious medical condition after using a diabetes drug such as Byetta, Bydureon, Victoza, Januvia, or Janumet, you may be able to seek compensation for your injury, as well as for damages incurred due to the injury. Attorney Group for Arkansas is here to help you understand your options in your unique situation, and help you determine if you have a diabetes drug lawsuit. If you decide to pursue a claim, we can connect you with a local Arkansas attorney who can assist you in filing a lawsuit. Contact us today to learn more in a free consultation.